Skip to main content

Table 1 Treatment-related toxicities occurring during the 6-months following Ad5-GUCY2C-PADRE vaccination

From: Split tolerance permits safe Ad5-GUCY2C-PADRE vaccine-induced T-cell responses in colon cancer patients

Toxicity Grade 1/2 Grade 3/4 Total (%)
Chills/Rigor 2 0 2 (20%)
Dizziness 1 0 1 (10%)
Diaphoresis 1 0 1 (10%)
Injection site or arm pain/swelling 2 0 2 (20%)
Aches 1 0 1 (10%)
Fever 1 0 1 (10%)